Molecular glue degraders: Lilly, AbbVie sign billion-dollar deals; BMS leads with three late-stage drugs

Data Compilation
#PharmaFlow

Pipeline Prospector March 2025: Trump’s FDA overhaul spooks biotech stocks; Roche, AbbVie, Novo ink obesity drug deals

Stock Recap
#PipelineProspector

Budesonide

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

85 API Suppliers, 24 USDMF, 28 CEP/COS, 7 JDMF, 7 EU WC, 15 KDMF, 36 NDC API, 43 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

76 Drugs in Development

76 Drugs in Development

INTERMEDIATES

7 Intermediate Suppliers

7 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

628 FDF Dossiers, 54 FDA Orange Book, 429 Europe, 23 Canada, 19 Australia, 39 South Africa, 64 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - 9MG, AEROSOL, FOAM;RECTAL - 2MG/ACTUATION, SPRAY, METERED;NASAL - 0.032MG/SPRAY, SUSPENSION;INHALATION - 0.25MG/2ML, SUSPENSION;INHALATION - 0.5MG/2ML, SUSPENSION;INHALATION - 1MG/2ML, CAPSULE, DELAYED RELEASE;ORAL - 6MG, CAPSULE, DELAYED RELEASE;ORAL - 9MG, CAPSULE, DELAYED RELEASE;ORAL - 3MG, AEROSOL, METERED;INHALATION - 0.08MG/INH;0.0045MG/INH, AEROSOL, METERED;INHALATION - 0.16MG/INH;0.0045MG/INH

RELATED EXCIPIENT COMPANIES

4 Evonik, 1 Rochem International Inc, 5 SPI Pharma, 13 DKSH, 4 Faran Shimi Pharmaceutical, 3 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 11 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 23 BASF, 1 Clariant, 14 Corel Pharma Chem, 4 DFE Pharma, 3 Doshion Polyscience, 2 Finar, 10 Gangwal Chemicals, 9 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 31 Kerry, 5 Kima Chemical, 6 Lonza Capsugel, 16 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 5 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 18 Roquette, 14 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 4 The Dow Chemical Company, 2 Valens Pharmachem, 2 Vasa Pharmachem, 2 Vertellus

EXCIPIENTS BY APPLICATIONS

69 Coating Systems & Additives, 63 Fillers, Diluents & Binders, 41 Controlled & Modified Release, 36 Thickeners and Stabilizers, 25 Solubilizers, 22 Direct Compression, 21 Film Formers & Plasticizers, 20 Granulation, 19 Taste Masking, 18 Lubricants & Glidants, 18 Topical, 13 Parenteral, 11 Co-Processed Excipients, 10 Rheology Modifiers, 9 Empty Capsules, 9 Disintegrants & Superdisintegrants, 9 Emulsifying Agents, 6 Chewable & Orodispersible Aids, 5 API Stability Enhancers, 5 Coloring Agents, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 1 Stock Recap #PipelineProspector, 131 News #PharmaBuzz

GLOBAL SALES INFORMATION

5 US Medicaid Prescriptions, 232 Regulatory FDF Prices, 37 Annual Reports

MARKET PLACE

19 APIs, 17 FDF Dossiers, 1 EXCIPIENTS

PATENTS & EXCLUSIVITIES

54 US Patents, 4 US Exclusivities, 2 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 4 USP, 13 Others

ANALYTICAL

3 BioAnalytical Methods

3 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
28/03/2025	Minakem	France	Daewoong Pharmaceutical Co., Ltd.	20221124-209-J-1409(A)	Undifferentiated budesonide	2023-07-19	Minakem Dunkerque production	France	224 avenue de la Dordogne Zone d'entreprises du Nord Gracht Dunkerque, 59640, France
28/03/2025	Axplora	Germany	Samoh Pharmaceutical Co., Ltd.	20200601-209-J-448	Budesonide	2020-06-01	Farmabios SpA@Microchem Srl	Germany	27027, via Pavia 1, GROPELLO CAIROLI-(PV), Italy@Via Turati, 2-29017 Fiorenzuola D'arda (PC), Italy

Budesonide

Budesonide

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

85 API Suppliers

24 USDMF

28 CEP/COS

7 JDMF

7 EU WC

15 KDMF

36 NDC API

43 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

76 Drugs in Development

INTERMEDIATES

7 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

628 FDF Dossiers

54 FDA Orange Book

429 Europe

23 Canada

19 Australia

39 South Africa

64 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - 9MG

AEROSOL, FOAM;RECTAL - 2MG/ACTUATION

SPRAY, METERED;NASAL - 0.032MG/SPRAY

SUSPENSION;INHALATION - 0.25MG/2ML

SUSPENSION;INHALATION - 0.5MG/2ML

SUSPENSION;INHALATION - 1MG/2ML

CAPSULE, DELAYED RELEASE;ORAL - 6MG

CAPSULE, DELAYED RELEASE;ORAL - 9MG

CAPSULE, DELAYED RELEASE;ORAL - 3MG

AEROSOL, METERED;INHALATION - 0.08MG/INH;0.0045MG/INH

AEROSOL, METERED;INHALATION - 0.16MG/INH;0.0045MG/INH

RELATED EXCIPIENT COMPANIES

4 Evonik

1 Rochem International Inc

5 SPI Pharma

13 DKSH

4 Faran Shimi Pharmaceutical

3 Gangwal Healthcare

6 Nanjing Well Pharmaceutical

1 Pfanstiehl

4 ACG Worldwide

11 Actylis

1 Aeon Procare

1 Alcedo Pharmachem

5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

23 BASF

1 Clariant

14 Corel Pharma Chem

4 DFE Pharma

3 Doshion Polyscience

2 Finar

10 Gangwal Chemicals

9 Ideal Cures Pvt Ltd

2 Ingredion Pharma Solutions

31 Kerry

5 Kima Chemical

6 Lonza Capsugel

16 Microlex e.U

1 Nanjing Bold Chemical

2 Nomisma Healthcare

1 Novo Excipients

1 Pharmatrans-Sanaq

5 Pluviaendo

2 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

18 Roquette

14 Seppic

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

10 Sigachi Industries

4 The Dow Chemical Company